• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:

    公开号:BR112012000384B1
    申请号:R112012000384
    申请日:2010-07-05
    公开日:2018-07-17
    发明作者:Eric Zoutman Dick；edward shannon Michael
    申请人:Medizone Int Inc；
    IPC主号:
    专利说明:

    (54) Title: PROCESS AND DISINFECTION SYSTEM FOR INSTALLATION INTENDED FOR HEALTH CARE WITH OXYGEN / OZONE MIXTURE (51) Int.CI .: A61L 2/20 (30) Unionist Priority: 06/07/2009 US 61 / 223,219, 1/18/2010 US 61 / 295,851 (73) Owner (s): MEDIZONE INTERNATIONAL INC.
    (72) Inventor (s): MICHAEL EDWARD SHANNON; DICK ERIC ZOUTMAN
    1/43
    Descriptive Report of the Invention Patent for PROCESS AND DISINFECTION SYSTEM OF INSTALLATION INTENDED FOR HEALTH CARE WITH OXYGEN / OZONE MIXTURE. FIELD OF THE INVENTION
    The present invention relates to disinfection systems for use in health care facilities, public health facilities and the like, to eliminate or at least reduce to acceptable levels, microbial residues that are resistant to conventional disinfectant and sterilizing systems. .
    BACKGROUND OF THE INVENTION
    Despite intensive preventive efforts in recent years in hospitals and other healthcare facilities, the incidence of life-threatening infections caused by a growing set of antibiotic-resistant bacteria (sometimes called superbugs) has grown significantly and now is imposing a serious problem on medical teams worldwide. According to an editorial in the journal Science (July 2008), the number of deaths in 2006 attributable to bacterial infections in healthcare facilities in the United States exceeded the death rate in the United States attributed to HIV / AIDS in the same year, and probably results in up to 70,000 deaths each year in the United States. All of this despite the maximum effort of health workers to properly clean their facilities and the equipment contained in such facilities.
    The main agents caused (bacteria) from nosocomial infections (nosocomial infections) are Clostridium difficile (C. difficiley, E. coli; Pseudomonas aeruginosa; Methicillin-resistant Staphylococcus aureus (MRSA); and Vancomycin-resistant Enterococcus (VRE).
    Approximately 5% of all intensive care hospitalizations in the United States develop a nosocomial infection with an incidence rate of five infections per thousand patient-days, and an additional expense in excess of $ 4.5 billion (Wentzel R, Edmond MD, The Impact of Hospital Acquired Blood Stream Infecctions, Emerg. Inf. Dis., Mar-April
    2/43
    2001: 7 (174)). When this rate is applied to 35 million patients admitted to 7,000 intensive care institutions in the United States, it is estimated that there are more than 2 million cases per year. It is estimated that nosocomial infections at least double the risk of mortality and morbidity for any admitted patient.
    The expressive, and growing, incidence of antibiotic-resistant bacteria in health care facilities has been referred to by some as the Silent Epidemic. In the international scenario, a survey by the World Health Organization of 55 hospitals in 14 countries representing four WHO regions (Europe, Eastern Mediterranean, Southeast Asia and Western Pacific) reported that an average of 8.7% of hospital patients had nosocomial infections. WHO estimates that, at any one time, more than 1.4 million people worldwide suffer and infection acquired in the hospital.
    Of particular concern in this context are the C. difficile and MRSA bacteria. Until recently, C. difficile was relatively uncommon, but it is now epidemic in many regions of the world. In fact, it is now recognized by an increasing number of public health officials as a worldwide epidemic (pandemic) with incalculable implications in the financial and health area. MRSA has been identified by the American Academy of Orthopedic Surgeons as the biggest concern in surgical procedures, and coinciding with recent journal articles that it constitutes a silent epidemic. In the current cleaning and sterilization procedures of a health care facility, C. difficile and MRSA, as well as those already mentioned E. coli; Pseudomonas aeruginosa; and Vancomycin-resistant Enterococcus (VRE), are treated ineffectively and subsequently removed, so that colonies of these pathogens accumulate in healthcare facilities, especially on porous surfaces, for example, carpets and curtains.
    Attempts to combat and exterminate nosocomial infections caused by bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus are hampered by the fact that the bacteria grow
    3/43 inside biofilms that protect them from different environmental factors. A biofilm is an aggregate of microorganisms where cells adhere to each other and / or to a surface. They are often embedded in a self-produced matrix of extracellular polymeric substance (EPS), a polymeric congregation generally composed of extracellular DNA, proteins and polysaccharides. Biofilms are formed on surfaces, for example, in the hospital environment, in the presence of water vapor.
    Free-floating microorganisms in the python (single cell) mode attach to a surface, and if not removed immediately, they will anchor more permanently to the surface. These first colonizers provide more diversified adhesion sites for the arrival of other cells, thus starting to build a matrix that maintains the cohesion of the biofilm and provides additional anchoring sites for incoming cells. Biofilm grows through a combination of cell division and recruitment. When the biofilm is established, the colonies of aggregated cells appear to be progressively more resistant to antibiotics. It has also been reported that biofilm bacteria apply chemical weapons in their defense against disinfectants and antibiotics (See Biofilm Bacteria Protect Themselves With Chemical Weapons, Dr. Carsten Matz et al., Helmholtz Cetre for Infection Research, Brauschweig, published at lnforniac.com, July 23, 2008).
    The bacteria that inhabit a biofilm have properties that differ significantly from the planktonic form of the same species, since the dense and protected environment of the film allows them to cooperate and interact in different ways. Traditional antibiotic therapy is usually not enough to eradicate chronic infections, and one of the main reasons for its persistence seems to be the growth capacities of bacteria within biofilms that protect them from diverse environmental factors.
    The imminent attacks on wars and bioterrorists using potentially lethal bacteria are also a growing concern. Some of the most harmful bacteria, for example, anthrax, are highly resistant to conventional sterilization treatments and agents. The contamination of public facilities with such bacteria constitutes a significant threat to human life with residual amounts of such bacteria, which makes it practically impossible to remove them with the use of current methods.
    BRIEF REFERENCE TO THE PREVIOUS TECHNIQUE.
    Current procedures for the sanitation of hospitals and other health care facilities have been progressively losing their effectiveness, resulting in the accumulation of deadly bacteria in the facilities. The rising costs of providing health services in most, if not all, countries advocate not investing time and effort beyond the minimum necessary in cleaning and sterilization procedures.
    Chlorinated solutions with and without ammonia are commonly used, but have shown limited success. Add to this challenge the fact that such solutions cannot be used in electronic devices normally installed in wards, recovery rooms, operating theaters, etc.
    Vaporized hydrogen peroxide (VHP) is highly effective when applied to smooth surfaces, but it is little or not effective on porous materials and fabrics. In addition, VHP is extremely harmful to electronic devices.
    Once a non-medical surface, such as carpets, curtains, bedding, porous material on ceilings and the like, has been impregnated with highly resistant pathogens, especially those that produce spores, such as C. difficile, that surface cannot be effectively disinfected using the current agents and processes available.
    Ozone is known to be a potent antibacterial, antifungal and antiviral agent. For more than 100 years it has been used for water purification. Its effectiveness is recognized against populations of Legionella bacterium, E. coli and Pseudomonas in such plants.
    Ozone use in health care facilities
    5/43 health, however, is problematic. Solutions that contain ozone are explosive when heated. Exposure to ozone is medically harmful, causing irritation of the membranes of the eyes and mucous membranes, pulmonary edema, and chronic respiratory disease if the low safety levels are exceeded. Furthermore, it is widely recognized as an environmental risk.
    Canada Patent Application 2,486,831 Arts et al., Describes the use of a combination of ozone and UV radiation to decontaminate air in an enclosure as a mobile isolation unit, a hospital enclosure and the like. The air is taken to flow through a portable unit that contains a filter exposed to ozone.
    United States Patent Application 7,404,624 Cumberland et al., Issued on August 5, 2008, describes methods for reducing allergens, pathogens, odors and volatile organic compounds in the air, using an atmosphere endowed with specific combinations of ozone concentration, concentrations of hydrogen peroxide, temperature and humidity delivered over a specific period of time. The patent contains an experimental report for the treatment of rooms in a residence, effectively treating the spores of Cladosporíum mold and Penicilliuml AspergilIus mold in the air of the room. No details were given about the precise conditions used. There is no demonstration or description of the treatment of contaminated surfaces in an enclosure. The general description of the patent states that selected conditions of ozone concentration, hydrogen peroxide, humidity and temperature are highly effective in eliminating molds and fungi transmitted by air in ozone concentrations below 6 - 9 ppm, but the precise conditions are not described. In general, the patent teaches the use in an atmosphere of 2 - 10 ppm of ozone, hydrogen peroxide that is between 75% - 150% by weight of the atmospheric concentration of ozone, at a temperature of 15 - 27 ° C and time 0.5 - 3 hours. It is claimed that several airborne pathogens, including bacteria, can be treated by this method, but no experimental evidence is offered.
    6/43
    Therefore, there is a lack of an effective, yet economical, system that promotes the disinfection of premises in healthcare facilities, including all of its contents. Such a system would drastically reduce (99.999% or above) at least the amounts of the five bacteria mentioned in all contaminated spaces that are of clinical and public health value. Furthermore, it is necessary to reach a ta level! microbial decontamination that allows the space to be deprived of its purpose exclusively for a minimum period of time, while remaining, in the meantime, safe and harmless to electronic equipment and other equipment in the enclosure. Consequently, the decontamination process should not require emptying the contents of the space in question, while the system is operated.
    SUMMARY OF THE INVENTION
    The present invention provides, in one aspect, an ozone-based disinfection system for enclosures and their contents inside all facilities for health care, mobile or stationary, and other essential infrastructure, such as schools and government buildings. Using such a system, gases containing ozone are delivered and applied to surfaces and equipment and objects contained in the enclosure. The application can be made through the simple contact of the gaseous atmosphere with the surfaces, or, in the case of surfaces that are difficult to clean, such as curtains, carpets and other fibrous surfaces, this can be done through a displacement system that promotes physical agitation of the surface (cleaning brushes, high pressure jets or similar, sometimes referred to in this purification document). Ozone-containing gases are applied in controlled concentrations and, in some cases, at high pressures found to be effective in destroying critical viral, bacterial and fungal pathogens found in environments, including, among others, the five bacteria especially inconveniences Clostridium difficile (C. difficiley E. coli; Pseudomonas aeruginosa; methicillin-resistant Staphylococcus aureus (MRSA); and vancomycin-resistant Enterococcus (VRE).
    7/43
    In addition to effectively eliminating aerosolized pathogens within a given space, the system of the invention also allows an operator to apply ozone-containing gases in predetermined concentrations of ozone directly to problematic surfaces in the room, with a physical stirring action and under pressure when appropriate. The system also includes an ozone depleting unit that removes residual ozone from the atmosphere of the enclosure. The entire system is portable and can be moved from room to room as needed, in addition to being harmless to the equipment contained in the room. Once the sterilization process is completed, the room can return to medical use within 20 minutes, with residual atmospheric ozone at an acceptable level of 0.04 ppm or less.
    BRIEF REFERENCE TO THE DRAWINGS
    Figure 1 of the accompanying drawings is a schematic illustration of an apparatus according to an embodiment of the invention, arranged within a room to be disinfected;
    Figures 2A and 2B are schematic illustrations of the physical agitation systems for use in the embodiments of the invention;
    Figure 3 is a schematic illustration of an apparatus according to the invention, in a portable mode of transport;
    Figure 4 is a schematic illustration of a test apparatus used to generate some of the test results disclosed below;
    Figure 5 is a schematic illustration of the test apparatus used to generate the results disclosed in Example 10 below.
    PREFERENTIAL MODALITIES
    A significant feature of the system according to certain embodiments of the invention is the ability to adjust a pressure of the ozone / oxygen gas mixture that is used for the purpose of disinfection. It has been found that, in many cases, effective disinfection of a room and its contents of bacterial contamination can be maximally achieved by pressurizing an atmosphere in the room with the ozone / oxygen mixture containing from about 10 to about 100 ppm of ozone, up until
    8/43 a pressure higher than normal atmospheric pressure, for example, from about 14.7 psi to about 100 psi. A localized pressurized air jet can also be used, which would make it unnecessary to raise the general pressure in the room. Raising the pressure of the enclosure may require an initial seal of the enclosure prior to the decontamination process. With many rooms where medical procedures are conducted, such as operating theaters, this is a simple process, as such rooms are designed to remain substantially sealed when in use for medical procedures. With other enclosures, some initial preparation of significance may be necessary.
    Another particularly preferred embodiment of the invention uses hydrogen peroxide, as well as ozone, in the gaseous disinfectant atmosphere. When ozone and hydrogen peroxide are used, it may not be necessary to increase the pressure inside the room. Particularly inconvenient bacteria that are likely to cause nosocomial infections in a hospital setting, namely, Clostridium difficile (C. difficile) ', E. coli; Pseudomonas aeruginosa; Methicillin-resistant Staphylococcus aureus (MRSA); Vancomycin resistant enterococcus (VRE), deposit on the surfaces of a hospital environment, such as stainless steel surfaces, ceramic surfaces and marble surfaces, and quickly form a biofilm where microorganisms thrive. The treatment with the combination of hydrogen peroxide and ozone, in the appropriate humidity, according to this preferred aspect of the invention, destroys the bacteria in the biofilm, either by the chemical attack of the biofilm to expose the Microorganisms to the biocidal action of ozone and peroxide of hydrogen, by the interference of the activity of bacterial cells in the biofilm by the combination of ozone / hydrogen peroxide employed, or by a combination of all these mechanisms, possibly with others.
    Therefore, according to this preferred embodiment of the present invention, in one aspect, a process is provided to combat bacteria in a confined space within an enclosure and contained in the biofilm on the surfaces within the enclosure, which comprises:
    9/43 create a disinfectant atmosphere in the enclosure that includes ozone in a concentration of 2 - 350 ppm by weight and hydrogen peroxide in an amount of 0.2-10 percent by weight, at a relative humidity of at least 60%;
    expose the biofilm-bearing surfaces containing live bacteria to the disinfectant atmosphere for a period of at least 30 minutes, sufficient for an effective extermination of the bacteria in the microfilm;
    and then remove ozone from the atmosphere, to a level of 0.04 ppm or less.
    Preferably, the disinfectant atmosphere has a relative humidity of at least 65%.
    Another preferred modality provides a process for disinfecting a room and its surfaces to combat at least one of the bacterial microorganisms Clostridium difficile (C. difficile); E. coli; Pseudomonas aeruginosa; Methicillin-resistant Staphylococcus aureus (MRSA); Vancomycin resistant enterococcus (VRE); Bacillus subtilus, and / or anthrax, which comprises exposing the room and its surfaces to a gaseous atmosphere that includes an effective amount of ozone and an effective amount of hydrogen peroxide, for a period of time that substantially reduces the levels of bacteria on the surfaces, and then removing residual ozone in the atmosphere of the enclosure, to a safe and reduced level.
    The process is particularly effective with or without physical agitation, in disinfecting stainless steel surfaces that abound in medical treatment facilities, and on which bacteria are persistent and difficult to destroy, due, at least in part, to their generation from a biofilm on such surfaces. The process is also effective in destroying and deactivating anthrax bacteria, as evidenced by its effectiveness against the well-established anthrax substitute, Bacillus subtilis.
    In accordance with another aspect of this modality, a portable system is also provided to quickly disinfect enclosures, surfaces and the equipment contained therein, comprising:
    10/43 an ozone generator to discharge a gas mixture including ozone into the enclosure;
    an ozone controller adapted to control an amount of ozone discharged;
    a source of hydrogen peroxide to discharge controlled amounts of hydrogen peroxide into the room;
    means to discharge hydrogen peroxide and ozone into the enclosure;
    humidity adjustment means adapted to raise or reduce the relative humidity of the room during treatment; and an ozone remover adapted to destroy ozone, to a safe level in the atmosphere of the enclosure for later human use.
    In some circumstances, it is beneficial to increase the efficiency and reduce the duration of the process, to operate at high pressure, even when ozone and hydrogen peroxide are used in the disinfectant gas. Thus, according to another aspect of the present invention, a process is provided to disinfect an enclosure of a health care facility, comprising:
    introduce a gas mixture into the enclosure that includes ozone and hydrogen peroxide in effective amounts;
    raise the pressure inside the room above atmospheric pressure, or introduce a stream of pressurized gas;
    physically shake the fibrous and porous surfaces inside the enclosure while the surfaces are exposed to a stream of pressurized hydrogen peroxide gas and an atmosphere containing at least 60% relative humidity ozone;
    return the room to atmospheric pressure; and, remove residual ozone from the atmosphere of the enclosure, to a safe level.
    Preferred amounts of ozone are about 20 - 350 parts per million in the atmosphere of the treatment gas, more preferably 20 - 200, even more preferably 20 - 90 parts per million in the
    11/43 gas mixture of oxygen / ozone, with a maximum preference of 35 - 80 ppm of ozone. The preferred amounts of hydrogen peroxide are the quantities supplied to the treatment atmosphere of the enclosure using an aqueous solution containing 0.2 - 10%, more preferably 1 - 5%, of hydrogen peroxide. In the description below, the percentages of peroxide used are sometimes expressed in terms of these percentages of the solution. The quantities are selected so that no serious deleterious effects are suffered by other equipment in the treatment area. The amount of hydrogen peroxide in the disinfectant atmosphere can be calculated from the volume of aqueous hydrogen peroxide evaporated in the disinfectant atmosphere, the volume of the room that is disinfected and the concentration of hydrogen peroxide in the starting solution. Exposure times of the enclosure and its surface to the ozone-containing atmosphere are suitably 30 minutes to about 120 minutes, preferably about 60 to about 105 minutes, and most preferably about 90 minutes. These times are limited in part by the need to clean the ozone enclosure (up to a maximum of 0.04 ppm) following the disinfection phase, and to return the enclosure to medical use within a reasonable period of time, with a full time between start and finish not exceeding 150 minutes. Ozone removal is an extremely fast and fully effective process. Both hydrogen peroxide and ozone (and any products that interact with them) must be removed before the enclosure returns to normal use.
    Another significant feature of the preferred embodiments of the present invention is the provision of a displacement system at the outlet end of the discharge. The eviction system permits the penetration of carpet, curtain and similar surfaces into the enclosure to gain access to the spores and / or colonies of kidnapped / hidden bacteria. The eviction system can be operated manually, with operators protected by a mask or protected clothing, or it can be operated remotely or be fully automated. It can take the form of one or more outgoing jets, with an association of
    12/43 manually operated jet pressure. It can take the form of a fixed or rotating brush with bristles of appropriate stiffness, alone or in combination with an outlet jet. Any form of effective eviction system to disrupt the stacking of carpet fabrics, upholstery fabrics and other similar items to access remote parts capable of harboring spores or bacterial colonies can be used. This includes non-physical applications, such as air jets. ultrasonic energy, radio frequency energy and electromagnetic waves, for example, capable of causing physical degradation and resulting in micro-physical movements of fibrous surfaces.
    Ozone for use in the present invention can be generated by any known means. In the case of corona or other generation of electrical oxygen discharge, the apparatus of the invention preferably includes a medical grade oxygen container. The oxygen container can be a standard pressurized container containing medical grade oxygen, of the type normally found in medical facilities. The oxygen in this container is supplied to an ozone generator, where the oxygen is subjected to electrical discharge, usually with high voltage alternating current, to convert small amounts of oxygen into ozone and produce a gas mixture of oxygen and ozone. The amount of ozone in the mixture is controllable by adjusting the electrical discharge voltage. Suitable ozone generators are known and are commercially available. The relative amounts of ozone generated are relatively small, expressed in parts per million (ppm), but the disinfectant power of ozone, especially in combination with the hydrogen peroxide according to this invention, is such that these small amounts of ozone are everything What is necessary.
    Alternative forms of ozone generation can be used, if that is the preference. Ultraviolet radiation of the appropriate wavelength, which strikes through oxygen or air, is an acceptable alternative. In this type of system, the air in the enclosure itself can be fed into the ozone generating unit to supply the oxygen necessary for conversion to ozone13 / 43 nio. Other usable methods of generating ozone include photocatalytic reactions, cold plasma, etc.
    The relative humidity of the treatment space must be at least 60% and preferably at least 65%, for effective disinfection. To ensure this, it is preferable to incorporate a humidifier into the system of the invention, using sterile water from an internal system reservoir to adjust and control the humidity of the emitting gas mixture. In this way, the desirable humidity for a more effective disinfection is obtained at the discharge point where the dislodging of a carpet or curtain surface can occur. The adjustable humidifier only needs to increase the humidity of the space to the desired level, and can be positioned anywhere within the space. When using hydrogen peroxide, in addition to ozone, the hydrogen peroxide vapor is conveniently applied, in controlled quantities, to the air / water vapor emitted by the humidifier and, therefore, is added to the gas mixture containing ozone / oxygen. Alternatively, hydrogen peroxide can be applied to the water used to humidify the target site. Hydrogen peroxide is commercially available as aqueous solutions of standardized concentrations of hydrogen peroxide. For use in the embodiments of the present invention, a standard solution with a known concentration of peroxide is suitably diluted with a fixed volume of distilled water. The peroxide charge is standardized based on the known water volume of the peroxide solution required to raise the relative humidity to the desired point, for example, 40 - 80%. From there, it is possible to calculate the amount of hydrogen peroxide in percentage of volume or ppm per volume introduced in the treatment facility.
    Certain systems according to the modalities of the invention may include a temperature controller and adjuster for the gas mixture. This can be a simple heater / cooler through which the incident oxygen and the oxygen / ozone mixture generated prior to discharge into the atmosphere of the enclosure passes. Although a simple adjustment of the room temperature using an external heating system
    14/43 room and thermostat can be effective, it is preferable to adjust the temperature of the gas mixture that is emitted, for a treatment of maximum effectiveness of the surfaces of the carpet and curtains. The ideal temperature range for decontamination of pathogens by ozone and ozone / hydrogen peroxide is 15 ° Ca30 ° C.
    The system of the invention further includes an ozone removal unit. Such units are known, and can be purchased commercially for use in the present invention. Depending on the volume of the room's atmosphere and the capacity of the ozone removal unit, more than one unit of this type can be incorporated into the system of the invention. Convenient ozone removal units are those that use activated carbon as a means of removal. These units act very quickly, and do not lead to the formation of dangerous reaction products. The inclusion of such units allows the treated facility to be ozone-free and to be returned to normal use quickly, an important resource where healthcare facilities are involved. Other types include catalyst-based systems, such as manganese oxide or other metal oxides, which can be heated to remove moisture, thermal destruction along with other metals, including platinum or palladium.
    Figure 1 of the accompanying drawings shows an operating room of the patient room 10, closed and ready for disinfection by means of a process according to an embodiment of the invention. The room is substantially sealed. Inside the room is a pressurized oxygen cylinder 12, supplying a humidifier 14 with oxygen gas and, therefore, an ozone generator 16, which includes electric discharge plates of variable voltage to adjust the amount of ozone that is generated. A heater and pressure controller (not shown) can be arranged close to the ozone generator inlet. The outflow of the oxygen / ozone gas mixture occurs through the exits of the enclosure 18, 20 to an atmosphere of the skirt 10, and through the rods 22A and / or 22B to a displacement medium in the form of purification brushes 24A and 24B mounted only15 / 43 on the outlet ends of the respective rods 22A, 22B. The heater, the pressure controller, the voltage supplied to the ozone generator 16 and the humidity level provided by the humidifier 14 are all controlled and adjusted from an external control panel 26 through the respective electrical connections 28, 30, 32 and 34. An oscillating fan 34 and an ozone depleting filter unit 36 are also arranged inside the room.
    A container of aqueous hydrogen peroxide solution 19 and associated air blower 21 is disposed inside the room 10 which, during operation, blows vaporized hydrogen peroxide in controlled quantities on the discharge rod 22A and 22B to mix with the outlet of ozone / oxygen in it. The amount of hydrogen peroxide that is supplied is controlled by adjusting the blower 21 by connecting it to the control panel 26. In an alternative arrangement, hydrogen peroxide can be supplied by generator 19 to humidifier 14.
    Figures 2A and 2B of the accompanying drawings show in more detail the shapes of the removal means 24A and 24B for use in the present invention, fixed at the outlet, the discharge ends of the respective rods 22. The removal means 24A has an outlet nozzle jet 38A at its end, and a generally circular plate 40 mounted on rod 22A near the discharge end. The rod 22A passes through a central opening 42 in a plate 40. The plate 40 has brush bristles 46A mounted on its lower surface, arranged in two arcs around the jet nozzle 38A and which project downwards until a point immediately beyond the nozzle outlet extension 38A. In use, the oxygen / ozone gas mixture or oxygen / ozone / hydrogen peroxide gas mixture leaves the 38A nozzle at a relatively high pressure, and can be directed by the operator holding the rod to an area of the carpet surface when while the operator rubs the area of the carpet surface with the 46A bristles.
    Figure 2B shows an alternative, but essentially similar, arrangement in which plate 40 is replaced by a platform with wheels 44 that carries two rotating brushes 46B and three jet outlets 38B for delivering oxygen / ozone / hydrogen peroxide at pressure , located before the 46B rotating brushes.
    Figure 3 of the accompanying drawings illustrates the portability 5 of a system according to the invention. The parts are numbered as in figure 1. A cart with 4 wheels 24 is provided, on which all the component parts of the system can be loaded for easy transport from one room to another. The control and instrumentation panel can be disconnected for transport, and reconnected and disposed on the outside when the device is located in another room for use as shown in figure 1. Cart 24 is removed while the system is in use, but is loaded with components after use, either for transport to another location or for storage.
    The operation of the system will be readily evident from the previous description about its component parts and their interconnection. The trolley 24 that carries the component parts is moved in the room 10 to be disinfected, and the parts are distributed around the room and connected together as shown in figure 1. An operator dressed in a safety suit and other suitable protective clothes enters in the enclosure and hold rod 22. The enclosure is sealed. The treatment conditions are regulated in the control panel 26, and the device is turned on so that the mixture of gas mixture of oxygen / ozone / hydrogen peroxide in controlled conditions of ozone concentration, hydrogen peroxide concentration, relative humidity, temperature and high pressure is emitted by the jet nozzle 38. The operator applies the gas mixture in jets to the surfaces of carpets, draped surfaces and other absorbent surfaces in the room, while rubbing the surfaces with the bristles 46. The room is pressurized above the atmospheric pressure, due to the introduction of the oxygen / ozone gas mixture. The pressure is monitored continuously by the control panel 26 to ensure safe working conditions for the operator, as well as the temperature, humidity and ozone concentration in the room. Smooth surfaces in the room may not need 17/43 without the action of the eviction medium, but are satisfactorily disinfected by contact with the atmosphere in the room, especially when hydrogen peroxide and ozone are used in combination. The oscillating fan 34 is operated throughout the procedure, to circulate the oxygen / ozone mixture throughout the room.
    After a pre-set procedure time, and after all the appropriate absorbent surfaces have been purified, a period not normally exceeding 90 minutes, the hydrogen peroxide supply (if used), the oxygen supply and the ozone generator are turned off . Then the ozone-depleting filter is operated, sucking the gases containing ozone, destroying the ozone and emitting pure oxygen from it. The enclosure can be opened at this point, the device disconnected and loaded onto cart 24, and the enclosure returned to normal use. EXPERIMENTAL EXAMPLES.
    Ideal and effective conditions for use in the present invention were determined using a laboratory apparatus as generally illustrated in figure 4 of the accompanying drawings.
    A single, pure colony of each of the aerobic test bacteria, namely E. coli; Pseudomonas aeruginosa; Methicillin-resistant Staphylococcus aureus (MRSA); and Vancomycin-resistant Enterococcus (VRE) was inoculated on a Columbia agar plate with 5% sheep blood. The plates were incubated at 35 ° C in ambient air for 18-24 hours. From the plate, 4-5 isolated colonies were selected and suspended in a triptych broth of soy to obtain a McFarland turbidity pattern equal to 0.5 (1.5 x 10 8 cfu / ml) measured with the use of a spectrophotometer. The inoculum was prepared by performing various serial dilutions of 0.9 ml of 0.85 NaCl broth with 0.1 mL of the original inoculum to 0.5 McFarland (6x10 times) to yield 10 '1, 10' solutions 2 , 10 ' 3 , 10 ~ 4 , 10' 5 , 10 6 and 10 ' 7 cfu / ml.
    The organisms were plated in three replications, where 0.1 ml of each solution was spread over the surface of the Columbia agar plates with sheep's blood. Two sets of plates (12 plates per organism) were subjected to an ozone / oxygen exposure in
    18/43 ozone concentrations (ppm), humidity and temperature conditions pre-selected in the illustrated device. The other sets of 2 were treated as controls, without any exposure to ozone, but kept at room temperature.
    For exposure to ozone, the device illustrated in general in figure 4 was used.
    The test plates were mounted inside a disinfection chamber 60, whose upstream end 62 had an ozone inlet port 64, a hydrogen peroxide vapor inlet port 65 (which was blocked in Examples 1-9 described below ), and a water vapor inlet port 66. A pressurized medical grade oxygen cylinder 68 was provided, which supplies an ozone generator 70 with oxygen, equipped with alternating current electric plates to which the variable voltage would be supplied through inlet control 72. The mixed oxygen / ozone gas outlet of the ozone generator 70 was fed to the ozone inlet port 64 of the disinfection chamber 60. A water vapor humidifier 74 supplied water vapor water at the inlet port 66. The disinfection chamber 60 additionally contained a heater / cooler (not shown), a temperature sensor 76, a pressure sensor 78, a humidity sensor 80 and an ozone sensor 82, connected electronically via the respective lines 84, 86, 88 and 90 to a control panel and monitor 92, connected to feed the oxygen cylinder 68 in order to control the flow for pressure adjustment purposes, to the ozone generator 70 to control and adjust the amount of ozone, the water vapor humidifier 74 to control and adjust the relative humidity in the disinfection chamber 60, and the heater / cooler to control and adjust the temperature in the chamber. These parameters were all pre-set on the control panel to the desired values and were automatically readjusted intrinsically to those values as the experiments progressed.
    An ozone-depleting filter 94 was connected to the downstream end 96 of the disinfection chamber 60 at outlet port 98, to destroy the ozone emitted by chamber 60 at the end of the experiment. The gases
    19/43 were circulated inside chamber 60, and expelled at the end of the experiment, using a fan 100 mounted on it. After placing the test plates in chamber 60, it was sealed until the end of each experiment.
    Control plates and ozone-treated plates were placed in an incubator at the same time. The plate counts were read using a microscope, and the numbers of colony forming units on each plate were counted. The spores were airborne.
    EXAMPLE 1
    A series of tests as described above was conducted in MRSA ATCC 33592. The microorganism carrier plates were exposed in the chamber to a mixed oxygen / ozone atmosphere containing 80 ppm of ozone, for 90 minutes at 20 ° C and 85% relative humidity. Duplicate test plates were run. 10 pL volume aliquots washed from the plates were serially diluted with inoculum, for the final dilution factors 10 ' 2 , 10' 3 , 10 ^, 10 ' 5 , 10' 6 and 10 ' 7 . Control plates, not subjected to ozone exposure, were prepared, and the plates incubated for 24 hours as described. The surfaces of the agar plates were eluted to remove the colonies of bacteria, and the eluted ones plated for examination under a microscope.
    The count of the active and reproductive colonies of bacteria in the eluted compositions, under a microscope, revealed that the eluates from the control plates in the 10 -2 dilutions, had 19 and 11 cfu (duplicate plates), and no cfu of the highest dilution plates, while the experimental plates exposed to ozone produced compositions that did not exhibit any cfu in any of the tested dilutions. A log reduction of 3.35 was achieved (8.3 log to 4.9 log).
    EXAMPLE 2
    The experiment in example 1 was repeated using the same bacterial strain, but exposing the test plates in the chamber to 50 ppm ozone in oxygen, at 20 ° C and 80% relative humidity.
    20/43
    The count of the active and reproductive colonies of bacteria in the eluted compositions, under a microscope, revealed that the eluates from the control plates in the 10 ' 2 dilutions, had 374, 415, 414 and 423 ufcs (plates with four replications), 33, 35, 38 and 37 ufcs of control plates at 10 ' 3 dilutions, had 4, 1, 2 and 2 ufcs at 10 4 dilution and no ufc at higher dilutions. The counts of the eluates from the treated plates revealed 27, 11, 42 and 58 ufcs active in the 10 ' 2 , 3, 1, 3 and 5 ufcs dilutions in the 10' 3 dilution (plates with four replicates), and no dilution plates ufc taller.
    EXAMPLE 3
    The experiment in Example 1 was repeated, except for use as a test organism for P. aeruginosa ATCC 27853. The same conditions of exposure to ozone, dilution, incubation and testing were used. On the test plates, active colony counts of 11 and 18 were found at the dilution of 1CT 2 , and active colony counts of 5 and 27 were found at the dilution of 10 ' 3 . At higher dilutions, there were no detectable colonies. In contrast, the control plates exposed to ozone showed extremely numerous colonies to be counted, in all dilutions up to and including 10 6 . A log reduction of 2.8 was obtained (yog from 7.9 to log 5.1).
    EXAMPLE 4
    The experiment in Example 3 was repeated, using the same test organism, but treating the test samples in the chamber with an ozone / oxygen gas mixture containing 50 ppm of ozone, at 80% humidity, for 90 minutes. Through identical test and recovery procedures, it was determined that the control boards had extremely numerous ufcs to be counted. The test plates, performed with two repetitions, had cfu counts of 212 and 183 at the 10 2 dilution; counts of 13 and 50 in the 10 ' 3 dilution; and no cfu at higher dilutions. EXAMPLE 5
    The experiment in Example 3 was repeated, but using the clinical strain 80269 of Enterococcus faecalis (high level of resistance to vancomycin) as a test organism, with a 90-minute exposure to the ozone / oxygen mixture of 35 ppm of ozone, at 21 ° C and 80% relative humidity. Control plate elutes (repeated) had extremely numerous CFU counts to be counted in the 10 ' 2, 10 3 and 10% dilution; ufc counts of 402 and 346 at the 10 ' 5 dilution; ufc counts of 35 and 25 at 10 ' 6 dilution; and ufc counts of 14 and at 10 7 dilution. In contrast, the eluates from the test plates (duplicates) produced cfu counts of 78 and 29 at the 10'2 dilution ; ufc counts of 47 and 6 at the 10 ' 3 dilution; 112 and 50 at 10 -4 dilution; ufc counts of 0 and 1 at 10 ' 5 dilution; ufc counts of 1 and 0 at the 10 ' 6 dilution; and cfu counts of 0 and 1 at the 10 7 dilution. A log reduction of 2.95 was obtained (log from 7.7 to log 4.7). EXAMPLE 6
    The experiment in Example 5 was repeated using the same VRE Clinical strain as the test organism, but with 90 minutes exposure to the ozone / oxygen mixture of 50 ppm ozone, at 20 ° C and 80% relative humidity. Control plate eluates (duplicates) had extremely numerous cfu counts to be counted in the 10 ~ 2 , 10 ' 3 and 10 4 dilution; ufc counts of 369 and 359 at 10 ' 5 dilution; ufc counts of 46 and 46 at the 10 6 dilution; and cfu counts of 9 and 2 at the 10 ~ 7 dilution. In contrast, the eluates from the test plates (duplicates) produced cfu counts of 50 in the 10 ~ 2 dilution; ufc counts less than 30 in the 10 ' 3 dilution; and cfu counts equal to 0 at higher 10 ' 5 dilutions.
    EXAMPLE 7
    The experiment in Example 3 was repeated, but using the ATCC 25922 strain of E. coli from the test organism, with 90 minutes exposure to the ozone / oxygen mixture of 35 ppm ozone, at 21 ° C and 80% relative humidity . Control plate eluates (duplicates) had extremely numerous cfu counts to be counted in the 10 ' 2 , 10' 3 and 10 4 dilution; ufc counts greater than 300 in the 10 ' 5 dilution; cfu counts of 95 and 66 at the 10 -6 dilution; and cfu counts of 3 and 10 at the 10 ' 7 dilution. In contrast, the eluates from the test plates (duplicates) produced cfu counts of 43 and 38 at the 10 ' 2 dilution; ufc counts of 25 and 1 at 10 ' 3 dilution; 6 and 15 in the IO -4 dilution; ufc counts of 3 and 10 in the 10 ' 5 dilution; and cfu counts equal to 0 at higher dilutions.
    A log reduction of 3.22 (log 7.8 to log 4.6) was obtained. EXAMPLE 8
    The experiment in Example 7 was repeated using the same E. coli ATCC 25922 strain as the test organism, but with a 90 minute exposure to the ozone / oxygen mixture of 50 ppm ozone, at 20 ° C and 80% humidity relative. Control plate eluates (duplicates) had extremely numerous cfu counts to be counted in the 10 2 , 10 ' 3 and 10' 4 dilution; cfu counts of 563 and 350 at 10 ' 5 dilution; ufc counts of 74 and 87 at 1 θ ' 6 dilution; and cfu counts of 7 and 7 at the 10 ' 7 dilution. In contrast, the eluates from the test plates (duplicates) produced cfu counts of 13 and 28 in the 10 2 dilution , cfu counts of 8 and 7 in the 10 ' 3 dilution; cfu counts of 7 and 5 at the 10 Λ dilution and 0 at all other higher dilutions.
    EXAMPLE 9
    A strain of C. difficile (non-toxigenic clinical strain # 135, Queens University Medical School, Kingston, Ontario, Canada) was also used as a test organism, but due to the recognized difficulties in growing C. difficile strains (requirements anaerobic, for example), a slightly different preparatory method was adopted.
    The C. difficile strain was streaked on pre-prepared Brucella blood agar plates 12-20 and incubated anaerobically for 48 hours at 35 ° C. Each plate was flooded with 5 ml of sterile distilled water and the bacterial colonies delicately scraped from the agar surface with a sterile plastic bacteriological handle. The resulting bacterial suspension was mixed and left to stand at room temperature in a sealed tube for 20 minutes to allow osmotic lysis of the vegetative forms of the bacteria. As the bacterial suspension was centrifuged at 3000 x gravity for 20 minutes to pellet the spores and remaining bacterial cells. The supernatant was discarded and the pellet resuspended in 5 - 7 milliliters of sterile distilled water and mixed vigorously to resuspend the remaining spores and bacterial cells. The steps
    23/43 above were repeated three times to produce a pellet consisting of C. difficile spores. To exterminate the remaining vegetative bacteria, the final suspension was placed in a heating block at 70 ° C for 20 minutes. The spores were stored in 100% ethanol at 4 ° C. This preparation produced approximately 1.5 x 10 5 cfu / ml of spores. Gram staining of the spore preparation confirmed that the suspension consists of spores with very few vegetative cells.
    Serial dilutions of 10 times the spore suspension in sterile Na Cl at 0.85% NaCI were carried out as previously described, and then the inoculation was carried out by spraying 0.1 ml of each dilution on the surface of BAK agar plates. The spore production of C. difficile was about 6 x 10 4 -2 x 10 6 cfu / ml. Some plates were exposed to ozone in the device illustrated as previously described, others were kept as controls.
    The test plates were exposed for 90 minutes to the ozone / oxygen mixture with 35 ppm ozone, at 21 ° C and 80% relative humidity. The next incubation was 48 hours under anaerobic conditions. The eluates control plates (duplicate) CFU counts were 113 and 50 10 2e 10 dilution and the dilution 10 10 '3; while the eluates from the test plates showed no cfu at the tested dilutions.
    A log reduction of 4 (log 4 to zero) was obtained.
    EXAMPLE 10
    Experiments conducted to simulate the problems commonly faced in most modern hospitals related to the decontamination of textile products, such as carpets and curtains, clearly demonstrated the superior effectiveness of direct pressurized airflow in a more static gaseous environment. An apparatus was used as illustrated diagrammatically in the attached figure 5. A chamber 100, closed while the experiments were in progress, contained close to one end a frame 102 that held a layer (disc) 104 of fibrous curtain material (sterile cotton gauze), impregnated with MRSA and dried so that it was formed a biofilm. An ozone-rich atmosphere is supplied
    24/43 in the chamber. An electric fan 106 with rotating blades 108 was arranged at 3 cm from the gauze, in order to blow the gases into the chamber through the gauze at high speed, to promote physical agitation of the gauze. A plate 110 containing a similarly impregnated exposed gauze 112 was disposed near the other end of chamber 100, so that it was exposed to the essentially static atmosphere in the chamber. A control gauze, which was similarly impregnated but received in the treatment, was also evaluated.
    The results are shown in Table 1 below. In table 1, columns A, B, C and D are the results in serial dilutions in 10 times, obtained by standardized procedure. The results measured on the gauze subjected to physical agitation are recorded as direct. The results on the gases in an essentially static atmosphere are recorded as indirect.
    Whatever the case, the combination of 80 ppm ozone and 1% H 2 O 2 at 80% relative humidity with an exposure time of 30 minutes proved to be superior to all other combinations that included 1% H 2 O 2 without ozone and 80 ppm of ozone without H 2 O 2 . In these experiments, the methodology used for microbiological procedures was identical to that previously described for the other experiments. Consequently, it is concluded that in order to obtain a bacterial log extermination of 6-7 in hospital environments where carpets and other textile products are commonly found, a pressure applicator or physical ozone / H 2 O 2 shaker is essential. Based on the experiments provided and other research, the incremental increase in bacterial extermination that can be achieved through a pressure applicator is on the order of 2 - 3 logs (100 - 1000 x greater).
    25/43
    TABLE 1
    THE Β8 «1ΒΒί · ί  n ) ¾ daddy h ’-qj i H feygi K -L i Cycle No. Orga-nismo Ozone(PPM) H202(%) EXP(min) Umi-dade n . Disco THE B ç D Con-trolley MRSA 0 0 ° 0 Con-trolley TNTC 180 2 0 If 1 MRSA 80 1 30 80 1 0 0 0 0 Direct 2 MRSA 80 1 30 80 2 77 11 2 1 Indi-straight 3 MRSA 0 0 60 80 3 TNTC TNTC 181 12 Direct 4 MRSA 0 0 60 80 4 TNTC 233 21 3 Indirect | 5 MRSA 0 1 60 80 5 220 34 0 0 Direct | 6 MRSA___ 1 60 80 6 245 112 0 llndi-0 jreto 7 MRSA 0 1 90 80 7 134 10 2 0 [Direct 8 MRSA 0 1 90 80 8 112 17 3 0 Straight index 9 MRSA 80 0 30 80 9 43.1..... 14 0 0 Direct 10 MRSA 80 0 30 80 10 112 15 3 0 Indi-straight 11 MRSA 0 1 90 80 11 86 12 0 0 Direct 12 MRSA 0 1 90 80 12 136 54 0 0 Indi- | straight |
    EXAMPLE 11
    Test bacteria, namely, Clostridium diffícile (C. difficiley, E.
    coli; Pseudomonas aeruginosa (PAU); Methicillin-resistant Staphylococcus aureus (MRSA); Vancomycin resistant enterococcus (VRE); were prepared according to the description for the previous experiments (see Example 1 for the preparation of aerobic bacteria, Example 9 for the preparation of C. diffícile). Bacillus subtilis (the anthrax substitute) was prepared analogously to the C. diffícile preparation, except that the bacteria were grown on Columbia agar plates with sheep blood incubated for 18-24 hours in room air at 35 ° C. They were grown separately in plates for 24 hours. From the plate, 4-5 isolated colonies were
    26/43 selected, and suspended in NaCI 0.85 to obtain a turbidity pattern of 0.5 on the McFarland scale (1.5 x 10 8 cfu / ml) measured using a spectrophotometer. The inoculum was prepared by making several serial dilutions of 0.9 ml of 0.85 NaCI broth with 0.1 ml of the original 0.5 McFarland inoculum (6x10 times) to produce 10 _1 , 10 -2 solutions , 10 ' 3, 10 4 ' 10 - 5 '10 6 and 10 7 cfu / ml. The organisms were plated in three repetitions, as previously described, where 0.1 ml of each solution was spread on the surface of Columbia agar with sheep blood (for aerobic bacteria) or anaerobic Brucella blood agar plates (for C diffícile and B. subtilis) on the plates, or on stainless steel plates. On agar, bacteria retain the planktonic mode. In steel plates, biofilms contain the shape of bacteria.
    For the steel plate experiments, 40 microliters of the original inoculum as prepared above were placed on the surface of a series of 1 cm diameter stainless steel discs. They were left to dry in a biological safety cabinet for approximately 45 minutes until the inoculum points were dry. The steel discs were placed in a sterile Petri dish to facilitate their transfer to the test chamber. Once dry, the Petri dish lid was placed over the disks, and they were carefully transferred to the treatment site where they were exposed to the ozone test conditions. An appropriate number of control discs remained covered in the biological safety cabinet and were not exposed to ozone testing conditions.
    Some of the plates were subjected to ozone / oxygen exposure using ozone at 80 ppm, 42 - 80% humidity and room temperature at approximately 22 ° C, for a period of 90 minutes, in the illustrated apparatus, as controls. Additional controls received no treatment with ozone or hydrogen peroxide, but were prepared and exposed in the same way.
    With reference to figure 4, the test plates were mounted inside the disinfection chamber 60, and treated with ozone and water vapor as previously described, but additionally using hydrogen peroxide supplied as a vapor to the chamber through the door. 65. The disinfection chamber 60 also contained the same heater / cooler system and sensors already described.
    The plates treated according to the invention were exposed to 80 ppm of ozone and hydrogen peroxide gas from a 1% or 3% aqueous solution, with the air blown through the aqueous solution in the apparatus illustrated to create the peroxide peroxide. gaseous hydrogen. Other conditions and exposure times were maintained in the same way.
    Immediately after exposure to the test conditions, and similar to the unexposed control discs, the stainless steel discs were vigorously mixed in 10 ml of 0.85% sterile saline using a high speed swirl mixer for 60 seconds to elute all surviving viable bacteria or spores. The eluted suspension, containing live and dead bacteria, is serially diluted 10 times in 0.85% sterile saline and the diluted bacteria were quantitatively plated on Columbia agar plates with sheep blood for aerobic bacteria or anaerobic blood agar plates. Brucella for C. diffícile, incubated under appropriate conditions, in three replications to determine the concentration of the original inoculum. The counts of the surviving colony were logarithmically transformed and the geometric mean calculated. The difference between the bacterial counts of the unexposed controls and the exposed test discs produced the logarithmic reduction in bacteria under the test conditions. If this procedure resulted in the absence of growth, 100% of the bacteria contained in the biofilm would have been exterminated by exposure to ozone / hydrogen peroxide.
    The agar plates after exposure were cultured in an incubator for 24 hours. The plates were then colored, examined under a microscope, and the numbers of colony forming units on each plate were counted.
    The results are shown in Table 2 below, as 10-fold reductions in live bacteria on the agar plate or steel plate,
    28/43 compared to the starting plate before any exposure. Therefore, a value of 1 means 10 times or a reduction of one log in relation to the control samples, which is not considered a significant effect. A value of 5 means that a log of 5 or a 99.999% reduction in live bacteria has been obtained, enough to be termed total disinfection, in practical terms. A value of 6 means that a log of 6 or a 99.9999% reduction in live bacteria has been obtained, which is defined internationally (CDC) as sterilization. The bacterial strains were in agreement with the reports of previous experiments. Bacillus subtilis originated from spores of ATCC 19659.
    TABLE 2
    Bacteria 80ppm Ozone alone H 2 O 2 3% alone 80 ppm Ozone + 1% H 2 O 2 steel Agar Steel agar steel C. difficile 4.5 2.5-3.0 1.5 1.00 6.5+ MRSA 4.5 5.0 1.5 1.5 7.0+ E. coli 4.0 3.5 2.0 1.0 7.0 VRE 4.5 3.5 1.0 1.0 6.5 DICK 4.0 3.0 2.0 0.5 7.0 BacillusSub 1.0 1.0 7.0+
    EXAMPLE 12
    Tables 3, 4, 5, 6, 7 and 8 below provide a summary of the experiments, and thus the combinations of ozone, H 2 O 2 , humidity and time of exposure were evaluated in terms of the ability to eliminate the following bacteria when artificially applied as a biofilm to non-porous surfaces, such as stainless steel discs: E. coli; Pseudomonas aeruginosa (PAU); Bacillus subtilis (the anthrax substitute). Clostridium diffícile (C. diffícile); Vancomycin resistant enterococcus (VRE); and methicillin-resistant Staph20 ylococcus aureus (MRSA), the same strains as above.
    The steel test discs and test agar plates were prepared, exposed and tested as described in Example ante29 / 43 rior, the exposure conditions are shown in the tables below. In some cases, indicated as a chamber, the tests were conducted according to the description in Example 10 and with a device in general as shown in figure 4. In other cases indicated as an enclosure, the tests were conducted exposing the discs and plates in a enclosed, as generally illustrated in figure 1.
    The results tables below also report a post-exposure period (PEEP), in minutes, which is the time interval between the end of exposure to ozone / peroxide and the beginning of the procedure for determining the results. This simulates the actual practice of disinfecting hospital rooms and similar environments, where the bacteria, after disinfectant treatment, die over a period of time. To allow this, it is preferable that at least 25 minutes elapsed from the end of the ozone / hydrogen peroxide exposure time before the disinfected room returns to normal service.
    30/43
    Table 3 - E. coli
    ui OOβWsOO.535. Ü···. Ç;.·.ϊ Q> .¾ O, t9 UJ Log 10 RED 5.99 5.99 5.99 5.99 6.02 8’9 00CD 8’9 6.8 X Cam /Enclosure Chamber Chamber Chamber Chamber Enclosure Chamber Π3s_ωAND«ÜO Chamber Chamber O PEEP 90 90 06 O O O O O O L ± _- Exp.i 06 09 45 45 09 25 LOCO 45 09 LU Moisture% 80-85 80-85 80-85 80-85 80-85 80-85 LOco1OCO 80-85 80-85 O sçCMOCMΈ x— x— O í 'QlcgOO 80 08 08 08 80L 80 OCO 80 80 QC Materiali Steel Steel Steel Steel Steel Steel OO< Steel Steel < CM ’ CO ΧΓ jb CO CO OX ”
    31/43
    Table 4 - Pseudo (continued)
    'Ά RED LOGO 0.5 O 7.23 O O .Λ ' ç ü (D IT CO —- ε CO CO CO CO - <0 l_ 1_ l_ ώ CO CO CO O AND AND F AND «CO «CO «CO «CO O O O O CL O LULU CL O O CO O O CO Hi 'T' ’ üir IT CO CLX Co LU ;. <3 -X_'J O O O O COQC CO CO CO CO fS® -Qí2 & ^ <D Ό LU CO g LO LO LO LO AND CO CO oo CO D ά O O O CO CO oo CO nPcr Q O I LO_ O T- CO CO s CL O CL * CO O O O O ~ eCO CO CO O Λ * dog . (! „Lí 1_ ω <D CO 2 '7J-. O O O O O O O O < < < < · “· CM CO m CO - "1·
    32/43, ço
    s
    Ξ3
    CO
    CO
    O
    CD
    QC1 O*CDO m CD OΙ- Ξ3Ç Ό + Z3 CD ç Σ3 O σ O
    33/43
    Table 6 - C. diff
    34/43
    Table 6 - C. diff (continued)
    T * Log10 RED 7.9 CDK t ' Cam /Enclosure Chamber Chamber O OOH PEEP O O ll -5 OiS* 5ε2 Exp. OCD OCD LU £coO<3 Moisture% 80-85 80-85 Q SPCMOCMX X— O 03(PPM) O00 OCO CO Material Steel Steel <t λ £ | - ”<N V CDKW
    LU cr>
    so u_
    TJ co σ
    - Log10 RED CD 0.66 1.44 0.22 1.08 5.74 5.74 5.74 O + - · ç. O (D ΣΕ ÇT F CO co CO CO Ç0 co CO CO <co dog co (0 co co co co co O AND F AND F F AND t F <0 <00 <co <co <co <co <0 <co O O υ O O O O O sÇB O ο H<1 ....CT3B.C/ PEEP O ANDOO O O Ό O O O O O CD CD CD CD CD CD CD CD A C CO > of Q_ LL CD X ; 1J-; ç LU CD O O O O O O O O (Λ CD CD CD CD CD CD CD CD CD <D CL Có z Ξ3Α 0) TO,'· Ό LU -OO COP :. O i0 10 10 t E AND 00 00 CO Q> Ξ3 O O LO LO 10 O O O B.C·.Ui 00 00 CO CD CD CO CO 00 χθ O*· CM Q O CM I O O O O O - - x— 2 0l O; 0. QC O O O O O O O co CO O O O xT 00 oo oo oo oo “Dog L_ QC 0) CO O O O O O O O O O O O O O O O O < < < < < < < < . ( - ., · ·, X -. ··· .- . V ί O C l CO- 10 CD oo CD •• T —... - _ * A
    35/43
    Table 7 - VRE (continued)
    <
    co £ T co
    O
    TZJ co σ
    ΛΟ
    CO
    CO
    O
    The <
    co cr
    UJ:>
    cr
    UJ>
    O
    of
    O
    CD çr
    It's <C0
    O
    CL
    LU
    UJ
    CL
    QX
    UJ
    UJ
    O'
    L_
    E <05
    O o
    CD
    The σ>
    CD
    T3
    CO g
    E = 3rd
    O
    CN
    X
    CL
    CL
    CO
    O
    CM
    36/43
    Table 8 - MRSA (continued)
    37/43
    Table 8 - MRSA (continued)
    38/43
    Table 8 - MRSA (continued)
    - CMLOCDCOCOOOvr-MSv.1 i. :SBfωtZ18 / Log10 RED 0.51 6.39 COO 1.32 6.43 6.43 6.36 6.36 6.36 9’9 9’9 COco -.ct- Cam / Enclosure Chamber Chamber Chamber Chamber Chamberi_ Enclosure EnclosureI Enclosure Enclosure Chamber Chamber Chamber Ü CLLUUJCL 90 06 OCD 90 O O -106 06 O 06 06L ... O - L1_ J Exp. 06 06 OCD OCD 90 06 09 60 45 06 OCD I 06 'ÜJ cb<DσajTOANDΞ3 80-85 80-85 LOCOIO00 LOCOlOCO ! 80-85 i_ 80-85 80-85_l 80-85 80-85 80-85 80-85 80-85 Q cr-CMOCMX O only V CO CO CO CO O sCLçyCOO 80 08 O OCO 80 80 80 80 08 08 80 08 'CQ- Material Steel Steel Steel OO< Steel Steel Steel Steel Steel Steel Steel Steel CO - - CM 29 30  CO J CM CO 33 co - LO CO ; <CO - co 38 -GRANDFATHER)’<Co
    39/43
    Table 8 - MRSA (continued)
    <NLOCDCOCOOO, · H <.......1 : /<ω a: «Si Log10 RED CO u-CD u-CD u-(O 00 CD CO 0.128 1,169 1.29 0.04 0.987 Cam / Enclosure Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber O PEEP O O O O O O O O O O O O LU Exp. 25 35 LO OCO 45 09 06 30 09 06 30 09 LU o x o Ό Cü T5 E = 3 80-85 80-85 LOCO1OCO toCOtO00 80-85i 80-85 80-85 45 LO 45 09 60 Q o x CM O CM ΣΕ - CMθ ' 0.2 0.2 0.2 0.2 O- § 'CLCL 'COO 08 80 OCO OCO 80 80 80 80 80 OCO 08 08 ω Material Steel Steel Steel OO< Steel Steel Steel Steel Steel Steel Steel Steel 3rd '42 CO IO - CD mr co CD’Στ O~ IO IO
    40/43
    Table 8 - MRSA (continued)
    - Log10 RED 1.86 x— CM CMLOxçco ~ 1,049 2.50 I 1 8,4521 H-COr- S-coí < N-CO 0.849 r-LQCM X ·· Cam / Enclosure Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber Chamber_1 Chamber -Q CMLD PEEP O O O O O O O O O O O O Ll_ MRSA-ATCC 339 Exp. 06 30 60 _ 30 09 06 30 60 06 30 09 uj Moisture% 09 80 80 08I 09 09 09 80 08 OCO 45 45 Q θ 'CNOCNX CMO 0.2 CMO CMO x— CO CO O O3 (PPM) OCO 08 80 OCO 08 80 80 OCO 08 Ooo 08 80 CO Material Steel Steel Steell. OO< Steel Steel Steel Steel Steel Steel Steel Steel CMr ^ 9 ’CO IO MOU mIO 56 > b 10 00^ 1ÍO 59 OCO CO CMCO COCD
    41/43
    Table 8 - MRSA (continued)
    42/43
    The findings regarding Bacillus subtilis clearly indicate that 80 ppm of ozone, H 2 O 2 at 1% with 80% relative humidity produces a log reduction of 6 (+) when these aerobic spores are exposed for 90 minutes. Given the singularities of these bacteria and the fact that they are routinely used as a substitute for anthrax, the combination of the above treatment parameters produces this highly effective device in a scenario of countermeasures against bioterrorism.
    The findings regarding Pseudomonas aeruginosa definitely show that 80 ppm of ozone, 1% H 2 O 2 with 80% relative humidity with an exposure time of 25 minutes produces a 100% extermination (7 + logs). Similar findings were observed when biofilms from E. coli samples on stainless steel discs were exposed for 25 minutes in a combination of 80 ppm ozone, 1% H 2 O 2 at 80% relative humidity.
    Regarding Clostridium difficile and vancomycin-resistant Enterococcus, the same combination of 80 ppm ozone, 1% H 2 O 2 and 80% relative humidity proved to be highly effective in achieving 100% elimination of bacteria in biofilms placed on a stainless steel surface and exposed for 45 minutes.
    The results summarized in Table 8 above clearly demonstrate that the same combination of 80 ppm ozone, 1% H 2 O 2 and 80% relative humidity reaches 100% extermination (log reduction 6+) when MRSA biofilms were exposed for 30 minutes.
    Conclusion
    The data provided in the previous tables clearly demonstrate that the process according to the invention is able to completely eliminate the bacteria contained in biofilm preparations on a non-porous hardened surface, such as stainless steel. Although minor adjustments to the exposure time are required for common pathogens found in the hospital setting (25 - 45 minutes), Bacillus subtilis and therefore its anthrax cousin, requires almost twice the exposure time, but these pathogens are little relevance for hospitals.
    43/43
    Therefore, an aspect of the invention is a process for disinfecting a room, which comprises introducing a gaseous mixture of oxygen / ozone into the room, raising the pressure inside the room above atmospheric pressure, physically stirring the fibrous and porous surfaces inside the room while the surfaces are exposed to the atmosphere containing ozone in relative humidity of at least 65%, return the room to atmospheric pressure, and remove residual ozone from the room's atmosphere, up to a maximum level of 0.04 ppm.
    Another aspect of the invention is a portable system for disinfecting enclosures and surfaces with ozone, comprising an oxygen container, an ozone generator supplied with medical grade oxygen from the oxygen container and discharging a mixture of oxygen and ozone, an ozone controller adapted to control the proportion of ozone in the oxygen and ozone mixture, a discharge tube to receive the mixture of oxygen and ozone from the ozone generator, the discharge tube having an outlet end, a physical agitation at the outlet end of the discharge tube, for physical agitation of surfaces with the oxygen / ozone mixture emitted by it, pressure adjustment means connected to the ozone generator arranged to adjust the pressure of the oxygen / ozone mixture discharged by the system of physical agitation and the pressure of the oxygen / ozone gas in the treatment area, means of temperature adjustment connected to the ozone generator nio and willing to adjust the temperature of the oxygen / ozone mixture discharged by the physical stirring system, humidity adjustment means adapted to humidify the treatment site to a relative humidity of not less than 65%, and an ozone remover adapted to receive the oxygen / ozone mixture from the environment in which the discharge tube is used and to remove ozone from the mixture.
    1/2
    权利要求:
    Claims (8)
    [1]
    1. Process to fight bacteria in a confined space within a biofilm enclosure on the surfaces within the enclosure, characterized by the fact that the process comprises:
    5 create a disinfectant atmosphere in the enclosure that includes ozone in a concentration of 2 - 350 ppm by weight and hydrogen peroxide in an amount of 0.2 - 10 percent by weight, in a relative humidity of at least 60%, where said amount of hydrogen peroxide is derived from a supplied solution of 0.2 - 10 percent hydrogen peroxide;
    10 expose the biofilm-bearing surfaces containing live bacteria in it to said disinfectant atmosphere for an effective period of time to cause substantial extermination, by at least a log reduction of 5, of the bacteria in the biofilm, the period of time being at least 30 minutes;
    15 and then remove ozone from the atmosphere, to a level of 0.04 ppm or less.
    [2]
    2. Process according to claim 1, characterized by the fact that the exposure time is from 30 minutes to 120 minutes, or from 60 to 105 minutes, or 90 minutes.
    20
    [3]
    3. Process according to claim 1 or 2, characterized in that the amount of ozone in the treatment gas atmosphere is 20 to 350 ppm, 20 to 200 ppm, or 20 to 90 ppm, or 35 to 80 ppm .
    [4]
    4. Process according to any one of claims 1 to 3, characterized by the fact that the amount of hydrogen peroxide
    25 in the disinfectant atmosphere is 1 - 5% and is derived from a supplied solution of 0.2 - 10 percent hydrogen peroxide.
    [5]
    Process according to any one of claims 1 to 4, characterized in that the temperature of the disinfectant atmosphere is 15 - 30 degrees C.
    6. Process according to any one of claims 1 to 5, characterized by the fact that the bacteria being fought are Clostridium difficile (C. difficile); E. coli; Pseudomonas aeruginosa;
    Petition 870180030462, of 4/16/2018, p. 4/8
    2/2
    Methicillin-resistant Staphylococcus aureus (MRSA); Vancomycin resistant enterococcus (VRE); or combinations of two or more of said bacteria.
    Process according to any one of claims 1 to
    [6]
    6, characterized by the fact that it includes the additional step of subjecting fibrous and porous surfaces within the enclosure to physical agitation while exposed to the disinfectant atmosphere, optionally in which physical agitation is conducted with the application of bristles, still optionally, in which physical agitation is conducted with the application of air pressure jets, and optionally, in which physical agitation is conducted with the application of ultrasonic energy, radiofrequency energy or electromagnetic waves, capable of causing physical disruption.
    Process according to any one of claims 1 to
    [7]
    7, characterized by the fact that biofilm-bearing surfaces are exposed to the localized current of the disinfectant atmosphere.
    Process according to any one of claims 1 to
    [8]
    8, characterized by the fact that the pressure of the disinfectant atmosphere when the biofilm-bearing surfaces are exposed to it is above atmospheric pressure, preferably from 101.35 to 689.48 kPa (14.7 to 100 psi).
    04/16/2018, p. 5/8
    类似技术:
    公开号 | 公开日 | 专利标题
    BR112012000384B1|2018-07-17|oxygen / ozone mixture health care facility process and disinfection system
    US11147650B2|2021-10-19|Sterile site apparatus, system, and method of using the same
    Morfill et al.2009|Nosocomial infections—a new approach towards preventive medicine using plasmas
    O'connor et al.2014|Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections?
    US9616145B2|2017-04-11|Healthcare facility disinfecting system
    EP2525838B1|2016-04-27|Bio-terrorism counteraction using ozone and hydrogen peroxide
    US8992829B2|2015-03-31|Sports equipment and facility disinfection
    US9616144B2|2017-04-11|Food-handling facility disinfection treatment
    CN108025182A|2018-05-11|Method and apparatus for sterilizing, sterilizing and sterilize
    US20130276357A1|2013-10-24|Combating insect infestations
    JP2019531105A5|2020-08-06|
    Song et al.2020|Development of a pulsed xenon ultraviolet disinfection device for real-time air disinfection in ambulances
    Matys et al.2020|Disinfectants and devices for surface and air disinfection in dental offices
    Brelles-Marino2016|Gas-discharge plasma: biofilm inactivation
    WO2015048903A1|2015-04-09|Healthcare facility disinfecting system
    CA2785850A1|2011-07-21|Bio-terrorism counteraction using ozone and hydrogen peroxide
    ES1237505U|2019-11-15|Sterilization system of hospital beds and equipment |
    Du et al.2012|A pilot study of atmospheric nonthermal plasma jet application on Staphylococcus aureus and Staphylococcus epidermidis
    WO2012037678A1|2012-03-29|Process for sterilization of air spaces and surfaces using advanced oxidation stress
    同族专利:
    公开号 | 公开日
    US8551399B2|2013-10-08|
    JP2012531979A|2012-12-13|
    CN102481383B|2015-11-25|
    MX2012000302A|2012-06-19|
    EP2451489A1|2012-05-16|
    EP2451489B1|2016-06-29|
    SG176977A1|2012-02-28|
    KR20120035206A|2012-04-13|
    BR112012000384A2|2017-06-13|
    EP2451489A4|2014-07-30|
    CA2735739C|2011-11-22|
    WO2011003179A1|2011-01-13|
    MX344243B|2016-12-08|
    US20120100037A1|2012-04-26|
    CN102481383A|2012-05-30|
    CA2735739A1|2011-01-13|
    IN2012DN00963A|2015-04-10|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US5316741A|1991-05-30|1994-05-31|Zontec Inc.|Ozone generator|
    US5972196A|1995-06-07|1999-10-26|Lynntech, Inc.|Electrochemical production of ozone and hydrogen peroxide|
    JPH0960931A|1995-08-30|1997-03-04|Takuma Co Ltd|Ultrasonic wave humidifying and sterilizing device|
    TW343923B|1996-01-22|1998-11-01|Duskin Co Ltd|Deodorization/odor-removal/disinfection method and deodorization/odor-removal/disinfection apparatus|
    US6045846A|1998-12-18|2000-04-04|Dionex Corporation|Produce sterilization|
    JP2001129062A|1999-11-04|2001-05-15|Mitsubishi Electric Corp|Method and apparatus for disinfecting floor surface|
    US7407624B2|2002-04-16|2008-08-05|Prompt Care, Inc.|Method for abatement of allergens, pathogens and volatile organic compounds|
    US7326387B2|2002-05-20|2008-02-05|Theodore A. M. Arts|Air decontamination devices|
    CH700121B1|2002-07-02|2010-06-30|Skan Ag|Method and device for decontamination of a clean room.|
    US20060104858A1|2003-01-06|2006-05-18|Potember Richard S|Hydroxyl free radical-induced decontamination of airborne spores, viruses and bacteria in a dynamic system|
    US7071152B2|2003-05-30|2006-07-04|Steris Inc.|Cleaning and decontamination formula for surfaces contaminated with prion-infected material|
    US20050129571A1|2003-12-10|2005-06-16|Steris Inc.|Ozone enhanced vaporized hydrogen peroxide decontamination method and system|
    CA2614354C|2005-07-07|2012-12-04|Steris Inc.|Room decontamination with hydrogen peroxide vapor|
    US7604780B2|2004-11-11|2009-10-20|Agrimond Usa Corporation|Ozone disinfection apparatus|
    NZ563822A|2005-05-03|2011-01-28|Ultreo Inc|Oral hygiene devices employing an acoustic waveguide|
    US7304288B2|2005-07-06|2007-12-04|The United States Of America As Represented By The Secretary Of The Navy|Laser pulse counter|
    US20070119699A1|2005-11-30|2007-05-31|Airocare, Inc.|Apparatus and method for sanitizing air and spaces|
    US20090263499A1|2008-04-18|2009-10-22|Ethicon, Inc.|Area decontamination via low-level concentration of germicidal agent|
    WO2011003179A1|2009-07-06|2011-01-13|Medizone International Inc.|Healthcare facility disinfecting process and system with oxygen/ozone mixture|US9616145B2|2009-07-06|2017-04-11|Medizone International, Inc.|Healthcare facility disinfecting system|
    WO2011003179A1|2009-07-06|2011-01-13|Medizone International Inc.|Healthcare facility disinfecting process and system with oxygen/ozone mixture|
    WO2015048903A1|2013-10-04|2015-04-09|Medizone International Inc.|Healthcare facility disinfecting system|
    EP2525838B1|2010-01-18|2016-04-27|Medizone International Inc.|Bio-terrorism counteraction using ozone and hydrogen peroxide|
    USRE47582E1|2009-07-28|2019-08-27|Sterifre Medical, Inc.|Free radical sterilization system and method|
    WO2012031365A1|2010-09-08|2012-03-15|Medizone International Inc.|Combating insect infestations|
    CA2846256C|2010-09-08|2017-03-21|Medizone International Inc.|Sports equipment and facility disinfection|
    WO2012031366A1|2010-09-08|2012-03-15|Medizone International Inc.|Food-handling facility disinfection treatment|
    WO2012037678A1|2010-09-20|2012-03-29|Medizone International Inc.|Process for sterilization of air spaces and surfaces using advanced oxidation stress|
    US20120282135A1|2011-04-15|2012-11-08|Samuel Richard Trapani|Room sterilization method and system|
    JP5839687B2|2012-02-03|2016-01-06|株式会社Ｉｈｉシバウラ|Oxidation treatment system|
    JP2013158699A|2012-02-03|2013-08-19|Ihi Shibaura Machinery Corp|Oxidation treatment method, and oxidation treatment system|
    JP2013158701A|2012-02-03|2013-08-19|Ihi Shibaura Machinery Corp|Oxidation treatment system|
    JP6253223B2|2012-07-25|2017-12-27|株式会社Ihi|Sterilizer|
    US9339572B2|2013-03-15|2016-05-17|EP Technologies LLC|Methods and solutions for killing or deactivating spores|
    WO2015168768A1|2014-05-05|2015-11-12|Sanuvox Technologies Inc.|Room decontamination system, method and controller|
    EP3142712B1|2014-05-13|2019-08-07|Rasirc, Inc.|Method of delivering hydrogen peroxide for decontaminating a material|
    JP6501489B2|2014-10-27|2019-04-17|学校法人東海大学|Sterilizer|
    JP6761563B2|2015-02-20|2020-09-30|三浦工業株式会社|Decontamination equipment and decontamination method|
    WO2017019722A1|2015-07-28|2017-02-02|EP Technologies LLC|Scrubbing device for cleaning, sanitizing or disinfecting|
    CA2996310A1|2015-08-31|2017-03-09|EP Technologies LLC|Methods of and system for generating antimicrobial wipes|
    CN105880198B|2016-03-22|2018-08-31|王慧丽|A kind of pediatric nursing cleaning sterilizing device|
    EP3471782A1|2016-06-17|2019-04-24|Sterifre Medical Inc.|Sterilization, disinfection, sanitization, decontamination, and therapeutic devices, systems, and methods|
    US11000613B1|2016-08-15|2021-05-11|Synergy Med Global Design Solutions, Llc|Transportable self-sterilizing clinical environment|
    US11224673B1|2016-08-15|2022-01-18|Synergy Med Global Design Solutions, Llc|Operating room intelligent platform and sterilization system|
    US10071177B1|2016-08-15|2018-09-11|Synergy Med Global Design Solutions, Llc|Hospital and operating room designs and sterilization methods|
    US10342246B2|2016-09-09|2019-07-09|Quail Systems, Llc|Ozone generator, system, and methods for retrofit of enclosed and air-conditioned environments|
    US11141499B2|2016-10-19|2021-10-12|Christopher Alexander CORSETTI|Sanitization system|
    US10692704B2|2016-11-10|2020-06-23|Gojo Industries Inc.|Methods and systems for generating plasma activated liquid|
    WO2020050864A1|2018-09-09|2020-03-12|SYNERGY MED GLOBAL DESIGN SOLUTIONS, LLC |Designs and sterilization methods for hospital and operating rooms|
    WO2020073075A1|2018-10-10|2020-04-16|Wellkleen Pty Ltd|Sterilisation device|
    法律状态:
    2018-02-14| B06T| Formal requirements before examination [chapter 6.20 patent gazette]|
    2018-04-10| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|
    2018-04-24| B06I| Publication of requirement cancelled [chapter 6.9 patent gazette]|
    2018-05-08| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|
    2018-07-17| B16A| Patent or certificate of addition of invention granted|
    优先权:
    申请号 | 申请日 | 专利标题
    US22321909P| true| 2009-07-06|2009-07-06|
    US29585110P| true| 2010-01-18|2010-01-18|
    PCT/CA2010/000998|WO2011003179A1|2009-07-06|2010-07-05|Healthcare facility disinfecting process and system with oxygen/ozone mixture|
    [返回顶部]